NCT06089486View on ClinicalTrials.gov

MARINER Trial: Multiparametric Cardiac PET for CAV Surveillance After Heart Transplantation

NARecruitingINTERVENTIONAL
Enrollment

576

Participants

Timeline

Start Date

January 8, 2024

Primary Completion Date

October 31, 2028

Study Completion Date

March 31, 2029

Conditions
Cardiac Allograft Vasculopathy
Interventions
DIAGNOSTIC_TEST

ICA

Patients will undergo annual CAV surveillance with ICA

DIAGNOSTIC_TEST

PET

Patients will undergo annual CAV surveillance with PET

Trial Locations (5)

Unknown

NOT_YET_RECRUITING

University of Calgary, Calgary

NOT_YET_RECRUITING

Mazankowski Alberta Heart Institute, Edmonton

NOT_YET_RECRUITING

Toronto-General Hospital - University Health Network, Toronto

NOT_YET_RECRUITING

Montreal Heart Institute, Montreal

K1Y 4W7

RECRUITING

University of Ottawa Heart Institute, Ottawa

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

Ottawa Heart Institute Research Corporation

OTHER